Atlas Trials

Efficacy of 30-day Duration of Fidaxomicin for Recurrent C. Difficile Infection

Clinical trial NCT02395848 · TERMINATED

Trial details

NCT number
NCT02395848
Sponsor
McMaster University
Status
TERMINATED
Phase
Phase 3
Study type
INTERVENTIONAL
Clostridium Difficile Infection
Start date
2015-07-01
Primary completion
2021-08-30
Enrollment
31

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.